
Full profile: /officials/C001095
Source: Congress.gov · FEC
Members who have signed on to support this bill since introduction. Source: Congress.gov.
3 cosponsors on record at Congress.gov. The named list is syncing into Govwatch and will appear here shortly — view on Congress.gov in the meantime.
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
2025-12-11
Source: Congress.gov
Previously
The legislation would establish protections for biological materials and genetic information developed by U.S. companies and researchers, preventing other countries from using or profiting from American biological innovations without permission or compensation. It aims to strengthen international agreements and enforcement mechanisms to stop the unauthorized use of U.S. biological intellectual property abroad, affecting pharmaceutical companies, biotech firms, universities, and research institutions that develop new medicines, crops, and biological products. The bill addresses concerns that valuable biological discoveries are being stolen or copied by foreign competitors, costing American businesses money and competitive advantage.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Bills by the same sponsor or covering overlapping subjects.